摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+)-Pumiliotoxin 251D | 73376-35-9

中文名称
——
中文别名
——
英文名称
(+)-Pumiliotoxin 251D
英文别名
Pumiliotoxin 251D;(6Z,8S,8aS)-8-methyl-6-[(2R)-2-methylhexylidene]-1,2,3,5,7,8a-hexahydroindolizin-8-ol
(+)-Pumiliotoxin 251D化学式
CAS
73376-35-9
化学式
C16H29NO
mdl
——
分子量
251.412
InChiKey
OKTQTXDNHCOLHT-AJKPHIATSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    349.1±30.0 °C(Predicted)
  • 密度:
    0.99±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    23.5
  • 氢给体数:
    1
  • 氢受体数:
    2

ADMET

毒理性
  • 毒性总结
普米里托毒素影响电压门控钙通道,干扰心脏和骨骼肌的肌肉收缩。它们还可能阻断细胞中的钠和钾通道,并抑制钙依赖性ATP酶。(L1073, L1077, A313, A315)
Pumiliotoxin affects voltage-gated calcium channels, interfering with muscle contraction in the heart and skeletal muscle. They also may block sodium and potassium channels in cells and inhibit calcium-dependent ATPase. (L1073, L1077, A313, A315)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 致癌物分类
对人类不具有致癌性(未被国际癌症研究机构IARC列名)。
No indication of carcinogenicity to humans (not listed by IARC).
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 健康影响
普米里托辛干扰心脏和骨骼肌的肌肉收缩。
Pumiliotoxin interferes with muscle contraction in the heart and skeletal muscle. (L1073)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 暴露途径
注射(刺伤/咬伤)(L1812);吸入(吸烟)(L1810)
Injection (sting/bite) (L1812) ; inhalation (smoking) (L1810)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 症状
一些pumiliotoxins(小型毒素)的症状包括部分瘫痪、行动困难、过度活跃,在某些情况下甚至会导致死亡。
Some of the symptoms of pumiliotoxins are partial paralysis, having difficulty moving, being hyperactive and in some cases death. (L1073)
来源:Toxin and Toxin Target Database (T3DB)

SDS

SDS:725a82451643f6fb5a33b2619f2f7afa
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (+)-Pumiliotoxin 251D 在 palladium on activated charcoal 氢气sodium acetate 作用下, 以 甲醇丙酮 为溶剂, 25.0 ℃ 、303.98 kPa 条件下, 反应 32.0h, 生成 Acetic acid (8S,8aS)-8-methyl-6-((R)-2-methyl-hexyl)-octahydro-indolizin-8-yl ester
    参考文献:
    名称:
    A new class of indolizidine alkaloids from the poison frog, Dendrobates tricolor. X-ray analysis of 8-hydroxy-8-methyl-6-(2'-methylhexylidene)-1-azabicyclo[4.3.0]nonane
    摘要:
    DOI:
    10.1021/ja00522a064
  • 作为产物:
    描述:
    methyl 2-<(S)-N-<(R)-α-methylbenzyl>pyrrolidin-2-yl>propenoate 在 sodium hydroxide 、 sodium tetrahydroborate 、 lithium aluminium tetrahydride 、 mercury(II) diacetate乙酸酐二异丁基氢化铝三甲基乙酸 作用下, 以 四氢呋喃甲醇乙醚甲苯 为溶剂, 反应 7.25h, 生成 (+)-Pumiliotoxin 251D
    参考文献:
    名称:
    Fox, David N. A.; Lathbury, David; Mahon, Mary F., Journal of the American Chemical Society, 1991, vol. 113, # 7, p. 2652 - 2656
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Total Synthesis of (+)-Pumiliotoxin 251D
    作者:Alexander Sudau、Winfried Münch、Jan-W. Bats、Udo Nubbemeyer
    DOI:10.1002/1099-0690(200210)2002:19<3315::aid-ejoc3315>3.0.co;2-2
    日期:2002.10
    The convergent total synthesis of pumiliotoxins by attachment of the side chain to a suitably functionalized core indolizidinone derivative has been achieved. The use of an aldol-type addition condensation strategy, intended to provide for the stereoselective generation of the exocyclic double bond, gave no satisfactory results. The method of choice was a Horner olefination. Initially, the reactant
    通过将侧链连接到适当功能化的核心吲哚嗪酮衍生物,已经实现了 pumiliotoxins 的会聚全合成。使用醛醇型加成缩合策略,旨在提供环外双键的立体选择性生成,没有给出令人满意的结果。选择的方法是霍纳烯化。最初,反应物核心吲哚里西酮通过酰胺烯醇化物的形成、烯醇磷酸酯的生成和最终的磷酸酯-膦酸酯迁移转化为 α 膦酰胺。酰胺基膦酸酯顺利地经历了霍纳型烯化,以允许在环外双键中成功引入具有高 Z 选择性的侧链。类似地,膦酸酯的引入和随后的烯化可以作为一锅法进行。内酰胺功能的最终还原去除提供了 (-)-8-epi-pumiliotoxin 209 F 和 (+)-pumiliotoxin 251 D。通过 X 射线分析证实了 pumiliotoxin 251 D 的结构。(© Wiley-VCH Verlag GmbH, 69451 Weinheim, Germany, 2002)
  • Total Synthesis of Pumiliotoxins 209F and 251D via Late-Stage, Nickel-Catalyzed Epoxide−Alkyne Reductive Cyclization
    作者:Katrina S. Woodin、Timothy F. Jamison
    DOI:10.1021/jo071132e
    日期:2007.9.1
    Pumiliotoxins 209F and 251D were synthesized using highly selective nickel-catalyzed epoxide−alkyne reductive cyclizations as the final step. The exocyclic (Z)-alkene found in the majority of the pumiliotoxins was formed stereospecifically and regioselectively, without the use of a directing group on the alkyne, and the epoxide underwent ring opening exclusively at the less hindered carbon to provide
    铝毒素209F和251D使用高度选择性的镍催化环氧化物炔还原环化反应作为最终步骤合成。在大多数pumiliotoxins毒素中发现的环外(Z)烯烃是立体定向和区域选择性形成的,无需在炔烃上使用导向基团,并且环氧化物仅在受阻较小的碳上开环以提供所需的叔醇。使用非对映选择性地将sulf代氧鎓阴离子加到脯氨酸衍生的甲基酮中来制备环氧化物。
  • Enantioselective total syntheses of pumiliotoxin B and pumiliotoxin 251D. A general entry to the pumiliotoxin A alkaloids via stereospecific iminium ion-vinylsilane cyclizations
    作者:Larry E. Overman、Kenneth L. Bell、Fumitaka Ito
    DOI:10.1021/ja00327a022
    日期:1984.7
  • Toxicity of Pumiliotoxin 251D and Synthetic Analogs to the Cotton Pest Heliothis virescens
    作者:Thomas M. Bargar、Renee M. Lett、Peter L. Johnson、James E. Hunter、C. P. Chang、Daniel J. Pernich、Mark R. Sabol、Michael R. Dick
    DOI:10.1021/jf00052a037
    日期:1995.4
    A series of 13 simplified analogs of frog skin derived pumiliotoxin indolizidine alkaloids was prepared and evaluated for their toxicity to the larvae of the important cotton pest Heliothis virescens. The alkyl side chain of pumiliotoxin 251D was replaced with a variety of substituents designed to influence or restrict-its conformation and its ability to act as a site of metabolic detoxification. Significantly, a substituent in the R configuration at the C-2' carbon of the side chain was required for toxicity. Computational studies suggested that this substituent may control the active conformation of the side chain. No structural modification led to a significant improvement in toxicity over the natural product.
  • DALY, J. W.;CARRAFFO, H. M.;PANNELL, L. K.;SPANDE, T. F.;SEVERINI, C.;ERS+, J. NATUR. PROD., 53,(1990) N, C. 407-421
    作者:DALY, J. W.、CARRAFFO, H. M.、PANNELL, L. K.、SPANDE, T. F.、SEVERINI, C.、ERS+
    DOI:——
    日期:——
查看更多

同类化合物

(6E,7R,8R,8aS)-6-[(4E,6S)-6-羟基-2,5-二甲基辛-4-烯-1-亚基]-8-甲基八氢中氮茚-7,8-二醇 pumiliotoxin B pumiliotoxin B (8R,8αS)-8-hydroxy-8-methyl-6-((Z)-2(R)-methyl-hexylidene)octahydroindolizin-7-one erythro pumiliotoxin PTX-B (6Z,8S,8aS)-6-[(2R,4E,6S)-6-(benzyloxy)-2,5-dimethyl-4-octenylidene]-8-{[tert-butyl(dimethyl)silyl]oxy}-8-methyloctahydroindolizine (6Z,8S)-6-[(E,6S)-6-hydroxy-2,5-dimethyloct-4-enylidene]-8-methyl-1,2,3,5,7,8a-hexahydroindolizin-8-ol (8R,8aS,6E)-8-Hydroxy-8-methyl-[(2R,4E,6S)-2,5-dimethyl-6-benzyloxymethyloxy-4-octenylidene]octahydroindolizin-7-done (8R,8aS)-8-hydroxy-6-[(E,2R,6S)-1-hydroxy-2,5-dimethyl-6-(phenylmethoxymethoxy)oct-4-enyl]-8-methyl-1,2,3,5,6,8a-hexahydroindolizin-7-one (+)-Allopumiliotoxin 323B' Pumiliotoxin 237A (1R,2R,9aS)-1-(benzyloxy)-2-hydroxy-3(E)-isobutylidene-1-methyloctahydroquinolizine (7S,8R,8aS)-8-(benzyloxy)-7-hydroxy-8-methyl-6-(E)-<(2R)-2-methylpentylidene>octahydroindolizidine (+)-allopumiliotoxin 267 A (+)-Pumiliotoxin 251D (3E)-(5S,6S)-5-hydroxy-3-[(R)-2-methylhexylidene]-5-methylazabicyclo[4.3.0]nonan-2-one (8S,8aS)-8-hydroxy-8-methyl-6(Z)-<2(R)-methylhexylidene>octahydro-5-indolizidinone (8S,8aS)-8-hydroxy-8-methyl-(6Z)-<(2R,4E,6S)-6-(benzyloxy)-2,5-dimethyl-4-octenylidene>octahydroindolizidine (+)-(15S)-pumiliotoxin A (+)-allopumiliotoxin 339A (6E,7S,8R,8aS)-8-methyl-6-[(E,2R)-2-methyl-5-[(4R,5R)-2,2,5-trimethyl-1,3-dioxolan-4-yl]hex-4-enylidene]-8-phenylmethoxy-1,2,3,5,7,8a-hexahydroindolizin-7-ol (+)-allopumiliotoxin 339 B (7R,8R,8aS)-8-(benzyloxy)-7-hydroxy-6(Z)-<6(R),7(R)-(isopropylidenedioxy)-2(R),5-dimethyl-4(E)-octenylidene>-8-methyloctahydroindolizine (+)-homopumiliotoxin 223G (6Z)-8-methyl-6-(2-methylhexylidene)-1,2,3,5,7,8a-hexahydroindolizine-7,8-diol (7R,8R,8aS,E)-6-((2R,6R,7R,E)-6,7-Dihydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizine-7,8-diol (8S,8aS)-6-[2,2-Dimethyl-hex-(Z)-ylidene]-8-methyl-octahydro-indolizin-8-ol (R,4E,8E)-8-((7R,8R,8aS)-7,8-Dihydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-4,7-dimethyloct-4-en-3-one (4E,7R,8Z)-8-((1S,9aS)-1-Hydroxy-1-methyltetrahydro-1H-quinolizin-3(2H,4H,6H)-ylidene)-4,7-dimethyloct-4-ene-2,3-diol (1S,9aS,Z)-3-((2R,E)-7-Hydroxy-2,5-dimethyloct-4-en-1-ylidene)-1-methyloctahydro-1H-quinolizin-1-ol (1S,9aS,Z)-3-((2R,E)-6-Hydroxy-2,5-dimethylnon-4-en-1-ylidene)-1-methyloctahydro-1H-quinolizin-1-ol (8S,8aS,Z)-6-((R,4E,6E)-2,5-Dimethylocta-4,6-dien-1-ylidene)-8-methyloctahydroindolizin-8-ol (8S,Z)-6-((2R,E)-6-Hydroxy-2,5-dimethylhept-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol (R,Z)-6-((8S,8aS)-8-Hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-5-methylhexan-2-one (8S,8aS,Z)-6-((2R)-4-Hydroxy-2-methylpentylidene)-8-methyloctahydroindolizin-8-ol (1S,9aS,Z)-3-((S)-3-Hydroxy-2-methylpropylidene)-1-methyloctahydro-1H-quinolizin-1-ol (8S,8aS,Z)-8-Methyl-6-((R)-2-methylpentylidene)octahydroindolizin-8-ol (6E)-8-methyl-6-(2-methylhexylidene)-8-phenylmethoxy-1,2,3,5,7,8a-hexahydroindolizin-7-ol (6Z)-6-[(E)-6-hydroxy-2,5-dimethyloct-4-enylidene]-8-methyl-1,2,3,5,7,8a-hexahydroindolizin-8-ol (8S,8aS,Z)-6-((2R)-5-Hydroxy-2-methylhexylidene)-8-methyloctahydroindolizin-8-ol Allopumiliotoxin 253a (8R,8aS,E)-6-((2R,6R,E)-6-Hydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizine-7,8-diol Pumiliotoxin 309a (6E)-8-methyl-6-(2-methylhexylidene)-1,2,3,5,7,8a-hexahydroindolizine-7,8-diol (+)-Pumiliotoxin B 8-Methyl-6-(2-methylhexylidene)-8-phenylmethoxy-1,2,3,5,7,8a-hexahydroindolizin-7-ol (1S,9aS,Z)-3-((2R)-6-Hydroxy-2,5-dimethyloctylidene)-1-methyloctahydro-1H-quinolizin-1-ol (8S,8aS,Z)-6-((R)-7-Hydroxy-2-methylheptylidene)-8-methyloctahydroindolizin-8-ol (8S,8aS,Z)-6-((R,E)-2,5-Dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol (8S,8aS,Z)-8-Methyl-6-((R,E)-2-methyl-5-((4R,5S)-2,2,5-trimethyl-1,3,2-dioxasilolan-4-yl)hex-4-en-1-ylidene)octahydroindolizin-8-ol